66
Views
1
CrossRef citations to date
0
Altmetric
Review Article

von Willebrand Disease and Pregnancy

, &
Pages 257-266 | Received 02 May 2000, Accepted 02 Jun 2000, Published online: 07 Jul 2009

References

  • von Willebrand E A. Hereditary pseudohaemophilia. Haemophilia 1999
  • Rodeghiero F, Castaman G, Dini E. Epidemiological investigation of the prevalence of von Willebrand's disease. Blood 1987; 69: 454–459
  • Castaman G, Eikenboom J C, Bertina R M, Rodeghiero F. Inconsistency of association between type 1 von Willebrand disease phenotype and genotype in families identified in an epidemiological investigation. Thromb Haemost 1999; 82: 1065–1070
  • Werner E J, Broxson E H, Tucker E L, Giroux D S, Shults J, Abshire T C. Prevalence of von Willebrand disease in children: a multiethnic study. J Pediatr 1993; 123: 893–898
  • Kadir R AED, Sabin C A, Owens D, Lee C A. Frequency of inherited bleeding disorders in women with menorrhagia. Lancet 1998; 351: 485–489
  • Lusher J M. Systemic causes of excessive uterine bleeding. Semin Hematol 1999; 36: 10–20
  • Claessens E A, Cowell C A. Dysfunctional uterine bleeding in the adolescent. Pediatr Clin North Am 1981; 28: 369–378
  • Kadir R AED, Sabin C A, Pollard D, Lee C A. Assessment of menstrual blood loss and gynaecological problems in patients with inherited bleeding disorders. Haemophilia 1999; 5: 40–48
  • Lee C A. Women and inherited bleeding disorders: menstrual issues. Semin Hematol 1999; 36: 21–27
  • Kadir R A, Sabin C A, Pollard D, Lee C A, Economides D L. Quality of life during menstruation in patients with inherited bleeding disorders. Haemophilia 1998; 4: 836–841
  • Foster P A. The reproductive health of women with von Willebrand disease unresponsive to DDAVP: results of an international survey. On behalf of the Subcommittee on von Willebrand Factor of the Scientific and Standardization Committee of the ISTH. Thromb Haemost 1995; 74: 784–790
  • Weiss H J, Sussman I I, Hoyer L W. Stabilization of factor VIII in plasma by the von Willebrand factor. Studies on posttransfusion and dissociated factor VIII and in patients with von Willebrand's disease. J Clin Invest 1977; 60: 390–404
  • Ruggeri Z M, De Marco L, Gatti L, Bader R, Montgomery R R. Platelets have more than one binding site for von Willebrand factor. J Clin Invest 1983; 72: 1–12
  • Fujimura Y, Titani K, Holland L Z, Russell S R, Roberts J R, Elder J H, Ruggeri Z M, Zimmerman T S. von Willebrand factor. A reduced and alkylated 52/48-kDa fragment beginning at amino acid residue 449 contains the domain interacting with platelet glycoprotein lb. J Biol Chem 1986; 261: 381–385
  • Plow E F, Pierschbacher M D, Ruoslahti E, Marguerie G A, Ginsberg M H. The effect of Arg-Gly-Asp-containing peptides on fibrinogen and von Willebrand factor binding to platelets. Proc Natl Acad Sci USA 1985; 82: 8057–8061
  • Ruggeri Z M. Mechanisms initiating platelet thrombus formation. Thromb Haemost 1997; 78: 611–616
  • Beguin S, Kumar R, Keularts I, Seligsohn U, Coller B S, Hemker H C. Fibrin-dependent platelet procoagulant activity requires GPIb receptors and von Willebrand factor. Blood 1999; 93: 564–570
  • Ginsburg D, Handin R I, Bonthron D T, Donlon T A, Bruns G A, Latt S A, Orkin S H. Human von Willebrand factor (vWF): isolation of complementary DNA (cDNA) clones and chromosomal localization. Science 1985; 228: 1401–1406
  • Bonthron D T, Handin R I, Kaufman R J, Wasley L C, Orr E C, Mitsock L M, Ewenstein B, Loscalzo J, Ginsburg D, Orkin S H. Structure of pre-provon Willebrand factor and its expression in heterologous cells. Nature 1986; 324: 270–273
  • Fowler W E, Fretto L J, Hamilton K K, Erickson H P, McKee P A. Substructure of human von Willebrand factor. J Clin Invest 1985; 76: 1491–1500
  • Wagner D D, Marder V J. Biosynthesis of von Willebrand protein by human endothelial cells: processing steps and their intracellular localization. J Cell Biol 1984; 99: 2123–2130
  • Federici A B, Elder J H, De Marco L, Ruggeri Z M, Zimmerman T S. Carbohydrate moiety of von Willebrand factor is not necessary for maintaining multimeric structure and ristocetin cofactor activity but protects from proteolytic degradation. J Clin Invest 1984; 74: 2049–2055
  • Turecek P L, Pichler L, Auer W, Eder G, Varadi K, Mitterer A, Mundt W, Schlokat U, Domer F, Drouet L O, Roussi J, van Mourik J A, Schwarz H P. Evidence for extracellular processing of pro-von Willebrand factor after infusion in animals with and without severe von Willebrand disease. Blood 1999; 94: 1637–1647
  • van Mourik J ABR, Huisveld I A, Fijnvandraat K, Pajkrt D, van Genderen P J, Fijnheer R. von Willebrand factor propeptide in vascular disorders: a tool to distinguish between acute and chronic endothelial cell perturbation. Blood 1999; 94: 179–185
  • Sussman I I, Rand J H. Subendothelial deposition of von Willebrand's factor requires the presence of endothelial cells. J Lab Clin Med 1982; 100: 526–532
  • Ruggeri Z M, Zimmerman T S. von Willebrand factor and von Willebrand disease. Blood 1987; 70: 895–904
  • Federici A B, Mannucci P M. Optimizing therapy with factor VHI/von Willebrand factor concentrates in von Willebrand disease. Haemophilia 1998; 4: 7–10
  • Zimmerman T S, Ruggeri Z M. von Willebrand disease. Hum Pathol 1987; 18: 140–152
  • Rodgers G M. Overview of platelet physiology and laboratory evaluation of platelet function. Clin Obstet Gynecol 1999; 42: 349–359
  • Vischer U MdMP. von Willebrand factor: from cell biology to the clinical management of von Willebrand's disease. Crit Rev Oncol Hematol 1999; 30: 93–109
  • Favaloro E J, Facey D, Henniker A. Use of a novel platelet function analyzer (PFA-100) with high sensitivity to disturbances in von Willebrand factor to screen for von Willebrand's disease and other disorders. Am J Hematol 1999; 62: 165–174
  • Fressinaud E, Veyradier A, Sigaud M, Boyer-Neumann C, Le Boterff C, Meyer D. Therapeutic monitoring of von Willebrand disease: interest and limits of a platelet function analyser at high shear rates. Br J Haematol 1999; 106: 777–783
  • Holmberg L, Nilsson I M. Von Willebrand disease. Clin Haematol 1985; 14: 461–488
  • Weiss H J, Meyer D, Rabinowitz R, Pietu G, Girma J P, Vicic W J, Rogers J. Pseudo-von Willebrand's disease. An intrinsic platelet defect with aggregation by unmodified human factor VHI/von Willebrand factor and enhanced adsorption of its high-molecular-weight multimers. N Engl J Med 1982; 306: 326–333
  • Mannucci P M. Treatment of von Willebrand disease. Haemophilia 1998; 4: 661–664
  • Silwer J. von Willebrand's disease in Sweden. Acta Paediatr Scand Suppl 1973; 238: 1–159
  • Fausett B, Silver R M. Congenital disorders of platelet function. Clin Obstet Gynecol 1999; 42: 390–405
  • Veyradier A, Jumilly A L, Ribba A S, Obert B, Houllier A, Meyer D, Girma J P. New assay for measuring binding of platelet glycoprotein IIb/IIIa to unpurified von Willebrand factor. Thromb Haemost 1999; 82: 134–139
  • Mohlke K L, Nichols W C, Ginsburg D. The molecular basis of von Willebrand disease. Int J Clin Lab Res 1999; 29: 1–7
  • Lankhof H DC, Schiphorst M E, Ijsseldijk M J, Bracke M, Furlan M, de Groot P G, Sixma J J, Vink T. Recombinant vWF type 2A mutants R834Q and R834W show a defect in mediating platelet adhesion to collagen, independent of enhanced sensitivity to a plasma protease. Thromb Haemost 1999; 81: 976–983
  • Takimoto Y. IF Type 2B Hiroshima: a variant of von Willebrand disease characterized by chronic thrombocytopenia and the presence of all von Willebrand factor multimers in plasma. Int J Hematol 1999; 70: 127–131
  • Pareti F I, Federici A B, Cattaneo M, Mannucci P M. Spontaneous platelet aggregation during pregnancy in a patient with von Willebrand disease type IIB can be blocked by monoclonal antibodies to both platelet glycoproteins lb and Ilb/IIIa. Br J Haematol 1990; 75: 86–91
  • Giles A R, Hoogendoorn H, Benford K. Type IIB von Willebrand's disease presenting as thrombocytopenia during pregnancy. Br J Haematol 1987; 67: 349–353
  • Valster F A, Feijen H L, Hutten J W. Severe thrombocytopenia in a pregnant patient with platelet-associated IgM, and known von Willebrand's disease; a case report. Eur J Obstet Gynecol Reprod Biol 1990; 36: 197–201
  • Casonato A SM, Bertomoro A, Fede T, Vasoin F, Girolami A. Pregnancy-induced worsening of thrombocytopenia in a patient with type IIB von Willebrand's disease. Blood Coagul Fibrinolysis 1991; 2: 33–40
  • Burrows R FKJ. Fetal thrombocytopenia and its relation to maternal thrombocytopenia. N Engl J Med 1993; 329: 1463–1466
  • Maharaj D, Walker I D, McEwan H P, Nisbet C E, Erskine J G. Coincidental Von Willebrands disease and immune thrombocytopenia in pregnancy: treatment with high dose intravenous immunoglobulin. Clin Lab Haematol 1986; 8: 227–231
  • Miller C H, Kelley L, Green D. Diagnosis of von Willebrand disease type 2N: a simplified method for measurement of factor VIII binding to von Willebrand factor. Am J Hematol 1998; 58: 311–318
  • Nesbitt I MHK, Preston F E, Peake I R, Goodeve A C. A common splice site mutation is shared by two families with different type 2N von Willebrand disease mutations. Thromb Haemost 1999; 82: 1061–4
  • Carter C BB. Acquired von Willebrand's disease in myeloproliferative syndrome: spontaneous remission during pregnancy. Thromb Haemost 1992; 67: 387–388
  • Aylesworth C ASR, Rick M E, Alving B M. Acquired von Willebrand's disease: a rare manifestation of postpartum thyroiditis. Am J Hematol 1995; 50: 217–219
  • Hawiger J. Formation and regulation of platelet and fibrin hemostatic plug. Hum Pathol 1987; 18: 111–122
  • Mannucci P M. Desmopressin: a nontransfusional form of treatment for congenital and acquired bleeding disorders. Blood 1988; 72: 1449–1455
  • Zingg H H. Vasopressin and oxytocin receptors. Baillieres Clin Endocrinol Metab 1996; 10: 75–96
  • Lethagen S. Desmopressin in the treatment of women's bleeding disorders. Haemophilia 1999; 5: 233–237
  • Smith T J, Gill J C, Ambruso D R, Hathaway W E. Hyponatremia and seizures in young children given DDAVP. Am J Hematol 1989; 31: 199–202
  • Casonato A SA, Pontara E, Zucchetto A, Rossi C, De Marco L, Girolami A. Post-DDAVP thrombocytopenia in type 2B von Willebrand disease is not associated with platelet consumption: failure to demonstrate glycocalicin increase or platelet activation. Thromb Haemost 1999; 81: 224–228
  • Ieko M, Sakurama S, Sagawa A, Yoshikawa M, Satoh M, Yasukouchi T, Nakagawa S. Effect of a factor VIII concentrate on type IIB von Willebrand's disease-associated thrombocytopenia presenting during pregnancy in identical twin mothers. Am J Hematol 1990; 35: 26–31
  • Foster P A. A perspective on the use of FVIII concentrates and cryoprecipitate prophylacrically in surgery or therapeutically in severe bleeds in patients with von Willebrand disease unresponsive to DDAVP: results of an international survey. On behalf of the Subcommittee on von Willebrand Factor of the Scientific and Standardization Committee of the ISTH. Thromb Haemost 1995; 74: 1370–1378
  • Chang A C, Rick M E, Ross Pierce L, Weinstein M J. Summary of a workshop on potency and dosage of von Willebrand factor concentrates. Haemophilia 1998; 4: 1–6
  • Dobrkovska A, Krzensk U, Chediak J R. Pharmacokinetics, efficacy and safety of Humate-P in von Willebrand disease. Haemophilia 1998; 4: 33–39
  • Sadler J E. Biochemistry and genetics of von Willebrand factor. Annu Rev Biochem 1998; 67: 395–424
  • Fischer B E. Recombinant von Willebrand factor: potential therapeutic use. J Thromb Thrombolysis 1999; 8: 197–205
  • Zhang Z, Lindstedt M, Blomback M, Anvret M. Effects of the mutant von Willebrand factor gene in von Willebrand disease. Hum Genet 1995; 96: 388–394
  • Kadir R A, Lee C A, Sabin C A, Pollard D, Economides D L. Pregnancy in women with von Willebrand's disease or factor XI deficiency. Br J Obstet Gynaecol 1998; 105: 314–321
  • Haseltine F PGM, Marchesi S, Spitz R, Dlugi A, DeCherney A A. Uterine embolization in a patient with postabortal hemorrhage. Obstet Gynecol 1984; 63: 78s–80s
  • Ito M YK, Toyoda N, Wada H. Pregnancy and delivery in patients with von Willebrand's disease. J Obstet Gynecol Res 1997; 23: 37–43
  • Cadroy Y, Grandjean H, Pichon J, Desprats R, Berrebi A, Fournie A, Boneu B. Evaluation of six markers of haemostatic system in normal pregnancy and pregnancy complicated by hypertension or pre-eclampsia. Br J Obstet Gynaecol 1993; 100: 416–420
  • Krishnamurthy M, Miotti A B. Von Willebrand's disease and pregnancy. Obstet Gynecol 1977; 49: 244–247
  • Hanna W, McCarroll D, McDonald T, Painter P, Tuller J, Chen J, Lange R. Variant von Willebrand's disease and pregnancy. Blood 1981; 58: 873–879
  • Takahashi H. Studies on the pathophysiology and treatment of von Willebrand's disease. VI. Variant von Willebrand's disease complicating placenta previa. Thromb Res 1983; 31: 285–296
  • Takahashi H, Hayashi N, Shibata A. Type IB von Willebrand's disease and pregnancy: comparison of analytical methods of von Willebrand factor for classification of von Willebrand's disease subtypes. Thromb Res 1988; 50: 409–418
  • Adashi E Y. Lack of improvement in von Willebrand's disease during pregnancy. N Engl J Med 1980; 1178
  • Ramsahoye B H, Davies S V, Dasani H, Pearson J F. Pregnancy in von Willebrand's disease. J Clin Pathol 1994; 47: 569–570
  • Rick M E, Williams S B, Sacher R A, McKeown L P. Thrombocytopenia associated with pregnancy in a patient with type IIB von Willebrand's disease. Blood 1987; 69: 786–789
  • Cohen S, Daitch J S, Amar D, Goldiner P L. Epidural analgesia for labor and delivery in a patient with von Willebrand's disease. Reg Anesth 1989; 14: 95–97
  • Milaskiewicz R M, Holdcroft A, Letsky E. Epidural anaesthesia and von Willebrand's disease. Anaesthesia 1990; 45: 462–464
  • Jones B P, Bell E A, Maroof M. Epidural labor analgesia in a parturient with von Willebrand's disease type IIA and severe preeclampsia. Anesthesiology 1999; 90: 1219–1220
  • Takafuta T, Fujimura K, Shimomura T, et al. Precise diagnosis by gene analysis and successful management of delivery in three patients with type IIB von Willebrand disease. Int J Hematol 1994; 60: 163–172
  • Watanabe T, Minakami H, Sakata Y. Successful management of pregnancy in a patient with von Willebrand disease Normandy. Obstet Gynecol 1997; 89: 859
  • Caliezi C, Tsakiris D A, Behringer H, Kuhne T, Marbet G A. Two consecutive pregnancies and deliveries in a patient with von Willebrand's disease type 3. Haemophilia 1998; 4: 845–849
  • Lipton R AAJ, Coller B S. Severe von Willebrand's disease during labor and delivery. JAMA 1982; 248: 1355–1357
  • McCammon R E. Pregnancy complicated by pseudohemophilia (Von-Willebrand's disease). J Indiana State Med Assoc 1967; 60: 1363–1366
  • Mullaart R A, Van Dongen P, Gabreels F J, van Oostrom C. Fetal periventricular hemorrhage in von Willebrand's disease: short review and first case presentation. Am J Perinatol 1991; 8: 190–192
  • Sadan O MP, Koller A B, Hofmeyr G J. Von Willebrand's disease in pregnancy. A case report. S Afr Med J 1987; 71: 456–456
  • Sorosky J KA, Nobert G F, Burchell R C. Von Willebrand's disease complicating second-trimester abortion. Obstet Gynecol 1980; 55: 253–254
  • Walker E HDK. The management of pregnancy in Von Willebrand's disease. J Obstet Gynaecol Br Common 1968; 75: 459–463
  • Chediak J R, Alban G M, Maxey B. von Willebrand's disease and pregnancy: management during delivery and outcome of offspring. Am J Obstet Gynecol 1986; 155: 618–624
  • Hoyer L W, Lindsten J, Blomback M, Hagenfeldt L, Cordesius E, Stromberg P, Gustavii B. Prenatal evaluation of fetus at risk for severe von Willebrand's disease. Lancet 1979; 2: 191–192
  • Thomas K B, Sutor A H, Altinkaya N, Grohmann A, Zehenter A, Leititis J U. von Willebrand factor-collagen binding activity is increased in newborns and infants. Acta Paediatr 1995; 84: 697–699
  • Greer I ALG, Walker J J, Forbes C D. Haemorrhagic problems in obstetrics and gynaecology in patients with congenital coagulopathies. Br J Obstet Gynaecol 1991; 98: 909–918

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.